TABLE 1.
Demographics and vaccination details among the three groups.
| Characteristic | Healthy, n = 273 | Neuropsychiatric conditions, n = 217 | Epilepsy, n = 491 | p |
|---|---|---|---|---|
| Gender, n male (%) | 128 (46.9) | 105 (48.4) | 243 (49.5) | .78 |
| Ethnicity, n Han (%) | 255 (93.4) | 205 (94.5) | 466 (94.9) | .90 |
| Age, years, mean ± SD | 31.12 ± 8.12 | 33.2 ± 12.37 | 30.4 ± 10.90 | .78 |
| History of febrile convulsions, n (%) | 7 (2.56%) | 6 (2.76%) | 89 (18.13%) | <.0001 |
| 1st injection, n (%) | 253 (92.7%) | 183 (84.3%) | 204 (41.6%) | <.0001 |
| 2nd injection, N2/N1 (%) a | 196 (77.5%) | 129 (70.5%) | 139 (68.1%) | .07 |
| Completed vaccine course, n (%) | 196 (71.8%) | 131 (60.4%) | 155 (31.6%) | <.0001 |
| Vaccine platforms, N1/N2 b | ||||
| Inactivated vaccine, 2 doses required | 236 (93.3) | 177 (96.7) | 187 (92.2) | .31 |
| Subunit vaccine, 3 doses required | 15 (5.9) | 4 (2.2) | 14 (6.9) | |
| Viral‐vector vaccine, 1 dose required | 2 (.8) | 2 (1.1) | 2 (.9) | |
| Willing to be vaccinated, N4/N5 c | 70.00 | 58.82 | 59.58 | <.0001 |
a
N1 is the number of participants who had the first vaccine. N2 is the number who had the second vaccine, excluding those who had viral vector vaccine, which requires only one injection.
b
N1 is the number of participants injected with the indicated vaccine. N2 is the number of participants injected with the first vaccine. One participant from the epilepsy group received an mRNA vaccine.
c
N1 is the number of uninjected participants who would be willing to have any kind of vaccine. N2 is the number of uninjected participants.